COVID-19 Vaccine Myocarditis: Cautious Reassurance in an Era of Dynamic Uncertainty
- PMID: 36480968
- PMCID: PMC9721358
- DOI: 10.1016/j.jacc.2022.10.010
COVID-19 Vaccine Myocarditis: Cautious Reassurance in an Era of Dynamic Uncertainty
Keywords: COVID-19; SARS-CoV-2; mRNA vaccine; myocarditis; pericarditis; prognosis; vaccination.
Conflict of interest statement
Funding Support and Author Disclosures This work is supported by the Canadian Institutes of Health Research, Public Health Agency of Canada and the Myocarditis Foundation. The authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures
Comment on
-
Prognosis of Myocarditis Developing After mRNA COVID-19 Vaccination Compared With Viral Myocarditis.J Am Coll Cardiol. 2022 Dec 13;80(24):2255-2265. doi: 10.1016/j.jacc.2022.09.049. J Am Coll Cardiol. 2022. PMID: 36480967 Free PMC article.
References
-
- Ahlborg B., Linroth K., Nordgren B. ECG-changes without subjective symptoms after smallpox vaccination of military personnel. Acta Med Scand Suppl. 1966;464:127–134. - PubMed
-
- Jacobson I.G., Smith T.C., Smith B., Wells T.S., Reed R.J., Ryan M.A. US military service members vaccinated against smallpox in 2003 and 2004 experience a slightly higher risk of hospitalization postvaccination. Vaccine. 2008;26:4048–4056. - PubMed
-
- Casey C.G., Iskander J.K., Roper M.H., et al. Adverse events associated with smallpox vaccination in the United States, January-October 2003. JAMA. 2005;294:2734–2743. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
